“Comparative Cardioprotective Effects of SGLT2 Inhibitors in Preclinical Models of Diabetic Cardiomyopathy” (2025) Vascular and Endovascular Review, 8(20s), pp. 1–9. doi:10.64149/J.Ver.8.20s.1-9.